Duke CFAR Microgrants
The CFAR Developmental Core Microgrants are one year awards that are intended to facilitate HIV/AIDS research by providing modest, but essential, resources that are not readily available from other sources. The Microgrant program is designed to support new NIH grant applications that will increase the HIV/AIDS funded research base at Duke.
Microgrant Awards are up to $20K for a 1 year award and are available throughout the year.
CFAR Microgrants of up to $20,000 will now be available on an ad hoc basis throughout the year. These one year awards are intended to facilitate HIV/AIDS research by providing modest, but essential, resources that are not readily available from other sources. The Microgrant program is designed to support new NIH grant applications that will increase the HIV/AIDS funded research base at Duke.
Microgrant Awards should be used for
- Generating preliminary data for planned HIV/AIDS-related NIH grant applications with review by CFAR leadership. (Target RFA/FOA(s) required)
- Bridge funding for generating preliminary data to address a weakness for HIV/AIDS-related NIH R grants that received scores, but were not funded. (Summary statement required)
- Performance of specific experiments requested by manuscript reviewers. Must be HIV/AIDS-related. (Manuscript review required)
Scope
Funds may be used for any HIV/AIDS research-related purpose, including salary/wages (e.g. temporary employee to assist in data collection or analysis), consultant costs, and supplies, or study subject incentives.
Eligibility
- Post-doctoral and Clinical Fellows. (Must show path to independent funding)
- Duke faculty (Priority given to Early Stage Investigators)
- Mid and Senior level investigators new to HIV research
- Applicants with a current K award must have NIH pre-approval
- Senior HIV investigators are rarely eligible and must have NIH pre-approval
- Funding is restricted to activities within the United States.
- Must have PI status prior to submitting an application*
*Any individuals that are not regular rank faculty (e.g., residents, post-docs, research scientists, non-regular rank faculty) and have an ongoing employment relationship with the University, may be approved to serve as a PI/PD on applications for external funding through the PI Eligibility request form.
Application
The application will be reviewed by an internal CFAR Committee. Turnaround time is < 1 month. Please email the completed application, along with your summary statement or manuscript review (if applicable) to Microgr.2y6jv7ecppq52ohn@u.box.com
Once you receive confirmation that your file was uploaded, please email cfar-dev-core@duke.edu to start the review process.
Duke CFAR Pilot Awards
The CFAR Developmental Core Pilot Awards support scientific studies for 1 year. The purpose of these awards is to develop preliminary data for peer-reviewed applications.
Proposals must target one of the NIH HIV/AIDS Priority Areas of Research.
Two types of Pilot Awards are available
- Standard Pilot Awards (7 pages) -- up to a maximum award of $100,000 direct funding
- Focused Pilot Awards (3 pages) -- up to a maximum award of $60,000 direct funding
Eligibility for CFAR Pilot Grant Awards
Faculty
- No prior R01 level funding in the HIV/AIDS field
- Applicants with prior R01 funding in other fields are encouraged to apply
Post-doctoral and Clinical fellows
- Applicants with a current K award must have NIH pre-approval
- T32 awardees cannot use CFAR award for training or stipends
- Separate letter of support from faculty mentor required, see Application information below
- PI Status must be submitted and obtained by department and approval document must be included in your CFAR pilot application.
*Questions on eligibility should be directed to the CFAR Developmental Core
Duke CFAR Administrative Supplements
NIH occasionally announces opportunities for administrative supplements. These are grants in specific aspects of HIV research that are offered to all CFAR sites for periods of one or more years. They are considered supplemental funding to the sites' CFAR grant.
When we are informed of a new administrative supplement, we announce the opportunity and application instructions by email to our members.
POSTED 28 FEBRUARY, 2023
CFAR Supplement Announcement – FY2023
- Each active CFAR can submit a maximum of two supplement applications from topics #1-3. Two applications can be in the same topic area.
- Each CFAR can submit a maximum of one supplement application for the CDEIPI topic (Topic #4).
- Each inter-CFAR working group (WG) is permitted to submit one meeting application (Topic #5) even if there are multiple inter-CFAR WGs led by a CFAR (e.g., a CFAR can submit two applications for this topic if they are submitting on behalf of 2 different inter-CFAR WGs).
Topic Areas:
1. Formative, intervention, and implementation research to explore delivery of long-acting PrEP in populations who may benefit
2. HIV and co-morbidities: Identification of mechanisms and strategies for optimal care that also reduce disparities
3. Community-led research topic
4. CFAR Diversity, Equity, and Inclusion Pathway Initiative (CDEIPI)
To participate in this process please send a brief (no more than a one-page) summary of your proposal identifying the topic area.
Internal Duke submission deadline: Monday, March 6th , 5pm EST to Mary Oris at mary.oris@duke.edu
POSTED 13 JANUARY, 2023
The FY2023 administrative supplements to support the Ending the HIV Epidemic in the U.S. (EHE) initiative is now published through a Notice of Special Interest. Please carefully review the application instructions.
Initial Selection Process:
Each CFAR is limited to three applications, there will be an internal review and selection process.
CFAR will sponsor an information session on Wednesday, January 18th at 12:00. Please attend to learn more about this extraordinary opportunity that is offered only to CFARs. Send an email to mary.oris@duke.edu for the link.
EHE Scientific Priorities for FY23:
- Syndemic Approaches to HIV Prevention, Treatment or Care
Objective: Using syndemic theory and approaches to (a) increase focus on intersecting diseases and social conditions that exacerbate health inequities, and (b) enhance the evidence base for effective successful approaches to assess, monitor, and intervene with respect to these intersections for optimal outcomes in HIV prevention or treatment. - Leveraging Pharmacies to Advance HIV Testing, Prevention, and Care
Objective: This topic will support research projects designed to further capacitate, field, and scale the routine delivery of HIV testing, prevention, and care services through pharmacists and pharmacy settings in the U.S. - Strategies to Improve Linkage to HIV Care and Services Post-Incarceration
Objective: Improving linkage and connection to mental health, substance use, social services, housing, job services, HIV care, and any other community resources post-incarceration. The goals are to optimize timely linkage to HIV care, retention, and viral suppression among people living with HIV (PLWH) re-entering their communities. - Cluster Detection and Response Strategies
Objective: Using cluster detection and response strategies to address identified service gaps, reduce HIV-related health disparities, and contain outbreaks.
To participate in this process please send a one-page summary of your proposal with the following:
- The problem under study
- Specific approach
- Does it address one or more of the 4 projects outlined in the NOSI
- Does it target one or more of 50 priority jurisdictions or the 7 states with a substantial rural HIV burden
- Future plans for follow up funding.
Submission deadline: January 25,2023, 5pm EST to mary.oris@duke.edu
PLEASE NOTE: We anticipate that the annual CFAR administrative supplements will be announced shortly. If your project does not fit with the above criteria, please consider this alternative funding pathway.